These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 86360)

  • 1. An unusual case of systemic lupus erythematosus.
    Ramaiah RS; Biagi RW
    Br J Clin Pract; 1979 Jan; 33(1):34. PubMed ID: 86360
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic studies in patients with systemic lupus erythematosus.
    Forman MD; Kaplan D
    Prim Care; 1978 Mar; 5(1):133-42. PubMed ID: 77535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of cytostatic drugs on antinuclear antibodies in visceral lupus erythematosus].
    Mantel W; Holtz G
    Z Rheumatol; 1974; 33(7-8):241-8. PubMed ID: 4139839
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antinuclear factors. I. Clinical and immuno-pathologic significance].
    Peltier AP
    Presse Med (1893); 1970 Oct; 78(45):1969-73. PubMed ID: 4098224
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute lupus erythematosus induced by procainamide].
    Manigand G; Foulon D; Perrigot M; Deparis M
    Sem Hop; 1973 Nov; 49(48):3207-10. PubMed ID: 4364913
    [No Abstract]   [Full Text] [Related]  

  • 7. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA.
    Sánchez A; Ossorio C; Alvaro-Gracia JM; Padilla R; Avila J
    J Rheumatol; 1990 Feb; 17(2):205-9. PubMed ID: 1690805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunofluorescent appearance of antinuclear antibodies and LE cells in connective tissue diseases].
    Kolarzowska B
    Pol Tyg Lek; 1970 Jan; 25(1):9-12. PubMed ID: 4189987
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is there any relationship between myasthenia gravis and disseminated lupus erythematosus?].
    Fucík J; Strejcek J
    Munch Med Wochenschr; 1970 Jul; 112(31):1408-11. PubMed ID: 4194245
    [No Abstract]   [Full Text] [Related]  

  • 10. [Colorimetric method of determining the interaction of sera from patients with systemic lupus erythematosus with native deoxyribonucleic acid].
    Tsebetsauer L; Gaĭzok O; Rovenski I; Zhitnian D
    Vopr Med Khim; 1976; 22(5):716-9. PubMed ID: 65054
    [No Abstract]   [Full Text] [Related]  

  • 11. Bullous pemphigoid associated with systemic lupus erythematosus.
    Jordon RE; Muller SA; Hale WL; Beutner EH
    Arch Dermatol; 1969 Jan; 99(1):17-25. PubMed ID: 4178218
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic liver disease. Inhibition of the LE-cell phenomenon in the blood.
    Holtz G; Schubert JC; Mantel W
    Med Chir Dig; 1972; 1(4):167-72. PubMed ID: 4118024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus].
    Marczak M; Kardaszewicz E; Sikora M
    Pol Tyg Lek; 1982 May; 37(12):339-40. PubMed ID: 6182556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma].
    Pawińska M; Gliński W; Blaszczyk M; Wranicz A
    Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical analysis of the correlation between the LE-phenomenon and antinuclear factor in systemic lupus erythematosus].
    Zhuravlev GI; Rodshteĭn OA; Shishkin VI
    Ter Arkh; 1971 Jul; 43(7):110-5. PubMed ID: 4113161
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of systemic lupus erythematosus simulating recurrent Quincke's edema and hypersensitivity rash].
    Weryńska-Przybylska J
    Reumatologia; 1969; 7(4):365-7. PubMed ID: 4189480
    [No Abstract]   [Full Text] [Related]  

  • 19. [An immunoenzyme method of detecting anti-DNA antibodies in lupus erythematosus].
    Rezaĭkina AV; Komarova VD
    Lab Delo; 1988; (1):40-3. PubMed ID: 2451074
    [No Abstract]   [Full Text] [Related]  

  • 20. Procainamide-induced systemic lupus erythematosus.
    Atkins CJ; Hamilton EB
    Proc R Soc Med; 1969 Feb; 62(2):197-8. PubMed ID: 4180268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.